Guidance on using non-investigational medicinal products in a clinical trial.
Similar Posts
Clinical trials for medicines: apply for authorisation in the UK
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Breast implants – patient perception of risk research
Information for patients, public and healthcare professionals
Transparency data: MHRA Performance Data
Performance data for MHRA key performance indicators (KPIs) and information on the expected timeline to complete a specific regulatory function.
Clinical trials for medicines: modifying a clinical trial approval
Guidance on the various types of modifications that can be made to a clinical trial approval.
Notice: Register of brokers authorised to deal in human medicines
Current listing of UK brokers authorised to broker human medicines, including company name, registration and address.
Regulation of AI in Healthcare
The MHRA is seeking evidence on the regulation of AI in healthcare to inform the recommendations of the National Commission into the Regulation of AI in Healthcare.